At the conclusion of this session you will be able to:
1. Understand the clinical significance of prenatal genetic testing, including its role in early detection of fetal genetic conditions, its impact on perinatal and neonatal outcomes, and how it informs patient counseling, pregnancy management, and newborn care.
2. Identify indications for referral to prenatal genetic counseling and MFM.
3. Differentiate screening vs. diagnostic tests (cfDNA vs. CVS/amniocentesis) and select appropriate follow up recommendations.
4. Demonstrate how to counsel a patient receiving results from cfDNA or carrier screening including explaining residual risk and providing resources for next steps.
Session date:
04/16/2026 - 12:00pm to 1:00pm EDT
Add to calendar:
- 0.00 Attendance
Faculty List:
Peer reviewer(s)
Mary Langley, PhD, MPH, BSN, ICPS
has no relevant financial relationships to disclose at this time.
Speaker(s)
Brittany Bowman, MGCS, CGC
has a financial relationship (Independent contractor) with Billion to One;.

Facebook
X
LinkedIn
Forward